Ipth-preconditioned bmsc-derived exosomes

Ipth-preconditioned bmsc-derived exosomes has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 31, 2026: “Encoding Intermittent Parathyroid Hormone Signals in Stem Cell Exosomes Enables Targeted Repair of Osteoporotic Bone Defects”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on ipth-preconditioned bmsc-derived exosomes

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Animals1

What did studies of ipth-preconditioned bmsc-derived exosomes find?

1

Studies of ipth-preconditioned bmsc-derived exosomes measured one outcome, hippo–YAP signaling.

Hippo–YAP signaling

upin rat cells1

1 study
  1. Ipth-preconditioned bmsc-derived exosomes activate hippo–YAP signaling in recipient cells.

    “Pharmacological perturbation confirmed that iEXOs activated the PA-PLD-LATS1/YAP axis in recipient cells, thereby promoting osteogenesis and angiogenesis while restraining osteoclastogenesis.”

    Cellsin recipient cells

    Encoding Intermittent Parathyroid Hormone Signals in Stem Cell Exosomes Enables Targeted Repair of Osteoporotic Bone Defects

    Research SquarePreprint

More on Hippo–YAP signaling

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months